GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Merge Healthcare Inc (FRA:MRJ) » Definitions » 14-Day RSI

Merge Healthcare (FRA:MRJ) 14-Day RSI : N/A (As of May. 04, 2024)


View and export this data going back to . Start your Free Trial

What is Merge Healthcare 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-04), Merge Healthcare's 14-Day RSI is N/A.

The industry rank for Merge Healthcare's 14-Day RSI or its related term are showing as below:

FRA:MRJ's 14-Day RSI is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 48.035
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Merge Healthcare's 14-Day RSI

For the Health Information Services subindustry, Merge Healthcare's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merge Healthcare's 14-Day RSI Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Merge Healthcare's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Merge Healthcare's 14-Day RSI falls into.



Merge Healthcare  (FRA:MRJ) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merge Healthcare  (FRA:MRJ) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Merge Healthcare 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Merge Healthcare's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Merge Healthcare (FRA:MRJ) Business Description

Traded in Other Exchanges
N/A
Address
Merge Healthcare Inc is a Delaware corporation founded in 1987. The Company develops enterprise imaging software solutions that facilitate the management of images to create a more effective and efficient electronic healthcare experience for patients and physicians. Its solutions are designed to help solve some of the difficult challenges in health information exchange today, such as the incorporation of medical images and diagnostic information into broader healthcare IT applications, the interoperability of proprietary software solutions, and the ability to improve the efficiency and cost effectiveness of its customers businesses. The Companys solutions optimize processes for healthcare providers ranging in size from single provider practices to large health systems, to the sponsors of clinical trials and medical device manufacturers. It operates in two reportable segments: Merge Healthcare mainly generates revenue from the sale of software including upgrades; hardware, professional services, maintenance and electronic data interchange services. Merge DNA derives the vast majority of its revenue from software, professional services and hosting through subscription arrangements. Its product portfolio provides products and services to its customers, including Image Interoperability Platform iConnect: This interoperability and connectivity platform enables hospitals, imaging centers, Integrated Delivery Networks and Health Information Exchanges to create information exchanges within their environments and with other entities.,Clinical and Financial Information Systems - Digital Imaging Solutions: Picture Archiving and Communication Systems, specialty workstations and related applications manage the image workflow of a medical enterprise; Clinical information systems: These systems provide a complete electronic record of a medical procedure across a variety of specialties including Merge OrthoEMR for orthopaedics, and Merge RIS for radiology; Revenue Cycle Management: It offer software and services for the revenue cycle management of physician practices, Software Development Toolkits, Technologies and Platforms - Merge toolkits, technologies and platforms provide software developers with the necessary resources to assist in the timely development of new products and enhance existing products and Hosted Software Solutions for Clinical Trial Data Management It provide hosted software solutions for the collection, aggregation, analysis, reporting and overall management of clinical trials information. Its strategy is to be a provider of integrated, healthcare IT solutions and services that improve the exchange of healthcare information. It is subject to regulation in the U.S. by the Food and Drug Administration, including periodic FDA inspections, in Canada under Health Canadas Medical Devices Regulations, and in other countries by corresponding regulatory authorities.

Merge Healthcare (FRA:MRJ) Headlines

No Headlines